Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q07954: Variant p.Lys1245Arg

Prolow-density lipoprotein receptor-related protein 1
Gene: LRP1
Feedback?
Variant information Variant position: help 1245 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Lysine (K) to Arginine (R) at position 1245 (K1245R, p.Lys1245Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are large size and basic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In KPA; reduced alpha-2 macroglobulin receptor activity; reduced protein abundance. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 1245 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 4544 The length of the canonical sequence.
Location on the sequence: help SYCAKHLKCSQKCDQNKFSV K CSCYEGWVLEPDGESCRSLD The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         SYCAKHLKCSQKCDQNKFSVKCSCYEGWVLEPDGESCRSLD

Mouse                         SYCAKHLKCSQKCDQNKFSVKCSCYEGWVLEPDGESCRSLD

Rat                           SYCAKHLKCSQKCDQNKFSVKCSCYEGWVLEPDGESCRSLD

Chicken                       SYCAKHLKCSQKCEQDKYNVKCSCYEGWMLEPDGESCRSLD

Baker's yeast                 -------------------------------------KALD
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 20 – 4544 Prolow-density lipoprotein receptor-related protein 1
Chain 20 – 3943 Low-density lipoprotein receptor-related protein 1 515 kDa subunit
Topological domain 20 – 4419 Extracellular
Domain 1223 – 1262 EGF-like 6
Disulfide bond 1233 – 1246
Alternative sequence 293 – 4544 Missing. In isoform 2.



Literature citations
Whole exome sequencing identifies LRP1 as a pathogenic gene in autosomal recessive keratosis pilaris atrophicans.
Klar J.; Schuster J.; Khan T.N.; Jameel M.; Maebert K.; Forsberg L.; Baig S.A.; Baig S.M.; Dahl N.;
J. Med. Genet. 52:599-606(2015)
Cited for: VARIANT KPA ARG-1245; CHARACTERIZATION OF VARIANT KPA ARG-1245; FUNCTION; INVOLVEMENT IN KPA;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.